← SynDRA
UNC-669
SynDRA canonical compound SYN0079801 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | L3MBTL1 | L3MBTL3 |
|---|
| Mechanism of action | L3MBTL antagonist |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- RefChem:1050568
- DTXCID801509853
- UNC669
- C15H20BrN3O
- MFCD26936345
- MLS006010250
- orb1305890
- SCHEMBL23682640
- CHEBI:95085
- EX-A257
- UNC0669
- UNC669?
- HMS3426C15
- HMS3653O18
- 3-BROMO-5-[4-(PYRROLIDIN-1-YL)PIPERIDINE-1-CARBONYL]PYRIDINE
- BDBM50341828
- s7373
- AKOS010495586
- CCG-267893
- SB19336
- NCGC00347957-01
- NCGC00347957-08
- NCGC00347957-09
- AC-35780
- AS-55925
- DA-46113
- HY-15839
- SMR004701326
- SW220043-1
- T2252
- 5-Bromo-N-(4-(pyrrolidinyl)piperidinyl)nicotinamide
- BRD-K21906513-001-03-2
- BRD-K21906513-001-04-0
- (5-bromo-3-pyridyl)-(4-pyrrolidin-1-yl-1-piperidyl)methanone
- P8H
- (5-bromo-3-pyridinyl)-[4-(1-pyrrolidinyl)-1-piperidinyl]methanone
Look up UNC-669 in the interactive SynDRA portal →